BYSI

Decheng Capital China Life Sciences USD Fund III, L.P.

CIK: 0001736814

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

BYSI Discusses FDA Fast Track Designation for Plinabulin. BeyondSpring reported that the FDA has granted Fast Track designation to its drug Plinabulin for use after immune checkpoint inhibitor therapy in non‑squamous non‑small cell lung cancer. The company also mentioned a strategic transaction related to the program. The announcement appears alongside recent pre‑market and after‑hours activity that highlighted BYSI among active health‑care stocks.

this person other insiders at BYSI

Transaction History

BYSI▼ Sell$80K
BYSI▼ Sell$148K
BYSI▼ Sell$30K
BYSI▼ Sell$47K
BYSI▼ Sell$183K
BYSI▼ Sell$4K
BYSI▼ Sell$7K
BYSI▼ Sell$13K
BYSI▼ Sell$4K
BYSI▼ Sell$31K
BYSI▼ Sell$1K
BYSI▼ Sell$1K
BYSI▼ Sell$5K
BYSI▼ Sell$8K
BYSI▼ Sell$875
BYSI▼ Sell$1K
BYSI▼ Sell$1K
BYSI▼ Sell$4K
BYSI▼ Sell$7K
BYSI▼ Sell$10K
BYSI▼ Sell$7K
BYSI▼ Sell$9K
BYSI▼ Sell$4K
BYSI▼ Sell$2K
BYSI▼ Sell$5K
BYSI▼ Sell$1K
BYSI▼ Sell$7K
BYSI▼ Sell$16K
BYSI▼ Sell$18K
BYSI▼ Sell$14K
BYSI▼ Sell$2K
BYSI▼ Sell$1K
BYSI▼ Sell$2K
BYSI▼ Sell$5K
BYSI▼ Sell$1K
BYSI▼ Sell$1K
BYSI▼ Sell$2K
BYSI▼ Sell$4K
BYSI▼ Sell$531
BYSI▼ Sell$4K
BYSI▼ Sell$5K
BYSI▼ Sell$6K
BYSI▼ Sell$6K
BYSI▼ Sell$97K
BYSI▼ Sell$6K
BYSI▼ Sell$4K
BYSI▼ Sell$5K
BYSI▼ Sell$2K
BYSI▼ Sell$45K
BYSI▼ Sell$12K
BYSI▼ Sell$5K
BYSI▼ Sell$2K
BYSI▼ Sell$563
BYSI▼ Sell$2K
BYSI▼ Sell$572
BYSI▼ Sell$21K
BYSI▼ Sell$784
BYSI▼ Sell$1K
BYSI▼ Sell$5K
BYSI▼ Sell$712K
BYSI▼ Sell$187K
BYSI▼ Sell$188K
BYSI▼ Sell$16K

We use analytics to understand how market-wall is used. No personal data is sold.